After a decade of blindness, a 78-year-old man regained his vision after a completely artificial cornea transplant. The success of this operation represents hope for millions of blind people around the world.
After four tissue transplants, all of which were unsuccessful, it represented the last hope for Operation Jamal Furani. The 78-year-old Israeli lost his vision ten years ago due to illness of the cornea (the transparent wall of the eye that covers the iris) that made him completely opaque. Today, he is the first patient in the world to have completely regained his vision with an artificial cornea.
Called Cornet Capro, this synthetic option is fully integrated into the lining of the eye, without the need for any donor tissue. The biomimetic implant integrates by stimulating existing cells in the eye. The procedure was performed in less than an hour at Israel’s Rabin Medical Center by Professor Irit Bahar, head of the Department of Ophthalmology.
Moment of great feeling
The man immediately regained his sight, removing his bandages the next day of operation. As we can see in this video, he was able to read a text written on a blackboard. Above all, he was finally able to recognize his daughter and see his grandson for the first time.
“The surgery was relatively simple and the result exceeded all our expectations,” commented Irit Bahar. “The removal of the bandages was a moment of great importance and great feeling. For us therapists, these types of events represent the highlight of our careers. “
“Lots of tears flowed into the room”, inventor of Cornea Corn KPro, Dr. The Guild says Litwin. “It was real. After years of hard work, I was very happy to get my vision back to a human being exactly one day after a procedure. “
Hope in terms of scattering
The operation was the first in a series of clinical trials involving approximately ten blind people who are ineligible for cornea transplant or whose operation has failed. After these first Israeli trials, others are expected to follow in Canada, France, the United States and the Netherlands.
To change the use of donor tissue in corneal transgenders, Cornet Vision aims to approve this device as a first-line treatment. In fact, diseased, cloudy or damaged corneas have so far been treated with a transplant. However, the world is facing a widespread shortage of implants. According to a recent study, only one cornea will be available for 70 needs. Therefore, the success of this first operation represents the hope of achieving vision for millions of people. Worldwide, there are more than 10 million blind people with corneal blindness.